logo
Share SHARE
FONT-SIZE Plus   Neg

Sears Holdings Reverses To Loss In Q4; To Spin Off Certain Stores - Quick Facts

Sears Holdings Corp. (SHLD) posted a large fourth-quarter GAAP net loss attributable to Holdings' shareholders of $2.40 billion compared with $374 million profit last year, with quarterly loss per share totaling $22.63, as against a profit of $3.43 a year ago.

On an adjusted basis, earnings per share plummeted to $0.54 from $3.67 in the comparable period prior year. On average, 3 analysts polled by Thomson Reuters expected earnings per share of $0.78 for the quarter. Analysts' estimates typically exclude one-time items.

Total revenues for the quarter decreased to $12.48 billion from $13.0 billion in the earlier year period. Analysts estimated revenues of $12.44 billion for the quarter. For the quarter, domestic comparable-store sales were down 3.4%, comprised of declines of 4.1% at Sears Domestic and 2.7% at Kmart.

The company attributed the declines in total revenue mainly to lower comparable store sales and the effect of having fewer Kmart and Sears Full-line stores in operation. The 2011 fourth quarter revenues included a decrease of $20 million, due to foreign currency exchange rates.

Separately, Sears Holdings reached a definitive agreement for the sale of eleven Sears full line store locations to General Growth Properties for a purchase price of $270 million, and the transaction may close in the next 45 to 60 days. Each of the Sears stores is part of an existing General Growth property.

In addition, the company plans to separate its Sears Hometown and Outlet Businesses and certain hardware stores through a proposed rights offering that is expected to raise nearly $400 million - $500 million. The rights would entitle holders to buy shares in the combined Sears Hometown and Outlet Stores businesses and certain hardware stores and would be transferred to holders of Sears Holdings stock.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
So far this year, 23 novel drugs have already received FDA approval. Now let's take a look at the biotech stocks waiting to hear from the FDA in July. President Donald Trump has continued his assault on one of his favorite targets on Wednesday, lashing out at major media outlets in a series of posts on Twitter. Trump singled out the New York Times and the Washington Post in his tweets, describing the newspapers as "fake news." Christoph, born on-board a Spirit flight destined to Dallas from Fort Lauderdale airport, can celebrate all his forthcoming birthdays in life with a free travel on Spirit airline.
comments powered by Disqus
Follow RTT